Bio-Rad Laboratories, Inc. Class A Common Stock vs Electronic Arts Inc. — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Electronic Arts Inc. trades at $206.65 (market cap $51.74B). The key difference: Electronic Arts Inc. is far larger — about 6.5× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Electronic Arts Inc. pays a 0.37% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | EA | |
|---|---|---|
Market Cap | $8.02B | $51.74B |
Sector | Health | Technology |
52-Week High | $339.75 | $206.65 |
52-Week Low | $241.71 | $147.79 |
Enterprise Value | $7.84B | $50.31B |
Dividend Yield | — | 0.37% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →EA is one of the world's largest third-party video game publishers and has transitioned from a console-based video game publisher to the one of the largest publishers on consoles, PC, and mobile. The firm owns number of large franchises, including Madden, FIFA, Battlefield, Apex Legends, Mass Effect, Dragon's Age, and Need for Speed.
Read more on EA →